Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$0.75 - $1.31 $2,427 - $4,239
3,236 Added 132.68%
5,675 $7,000
Q1 2024

May 14, 2024

BUY
$0.79 - $1.14 $1,563 - $2,256
1,979 Added 430.22%
2,439 $2,000
Q4 2023

Jan 31, 2024

BUY
$1.02 - $2.57 $134 - $339
132 Added 40.24%
460 $0
Q3 2023

Nov 13, 2023

SELL
$2.52 - $5.69 $556 - $1,257
-221 Reduced 40.26%
328 $0
Q2 2023

Aug 14, 2023

SELL
$5.0 - $7.66 $690 - $1,057
-138 Reduced 20.09%
549 $2,000
Q1 2023

May 08, 2023

SELL
$3.54 - $6.66 $619 - $1,165
-175 Reduced 20.3%
687 $4,000
Q4 2022

Feb 13, 2023

SELL
$2.11 - $4.3 $274 - $559
-130 Reduced 13.1%
862 $3,000
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $2,112 - $3,968
992 New
992 $2,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $39M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.